EP4 activation has also been associated with increased breast cancer cell invasion and metastasis through epidermal growth factor receptor transactivation, which can be blocked by EP4 antagonists in murine models of breast cancer (Ma et al, 2006; Tönisen et al, 2017). This evidence concerns the gene EGFR and breast cancer.